Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 24637998

Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: Clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2014 Apr 20
First author
Raemaekers JM

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2014 Apr 20;32(12):1180-2. doi: 10.1200/JCO.2013.54.6259.
    note
    Source null
    related pmid
    24638010
    relationship
    Comment in

Authors and identifiers

  1. name
    Raemaekers JM
    type
    Author
  2. name
    André MP
    type
    Author
  3. name
    Federico M
    type
    Author
  4. name
    Girinsky T
    type
    Author
  5. name
    Oumedaly R
    type
    Author
  6. name
    Brusamolino E
    type
    Author
  7. name
    Brice P
    type
    Author
  8. name
    Fermé C
    type
    Author
  9. name
    van der Maazen R
    type
    Author
  10. name
    Gotti M
    type
    Author
  11. name
    Bouabdallah R
    type
    Author
  12. name
    Sebban CJ
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Raemaekers JM
    type
    Author
  2. name
    André MP
    type
    Author
  3. name
    Federico M
    type
    Author
  4. name
    Girinsky T
    type
    Author
  5. name
    Oumedaly R
    type
    Author
  6. name
    Brusamolino E
    type
    Author
  7. name
    Brice P
    type
    Author
  8. name
    Fermé C
    type
    Author
  9. name
    van der Maazen R
    type
    Author
  10. name
    Gotti M
    type
    Author
  11. name
    Bouabdallah R
    type
    Author
  12. name
    Sebban CJ
    type
    Author
bibliography ids
  1. nci-bib-72dc2a804880736ac0a4d47b
book metadata
content sha256
353979f7c6a2ae44f9258e0cc8162052ea6aea9885f2523fb685a0c63f3de8e0
document type
citation
dois
  1. 10.1200/JCO.2013.51.9298
electronic publication date
display
2014 Mar 17
precision
day
year
2014
evidence scope
bibliographic_metadata_only
id
pubmed:24637998
immutable id
pubmed:24637998@353979f7c6a2ae44f9258e0cc8162052ea6aea9885f2523fb685a0c63f3de8e0
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
12
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
1188-94
volume
32
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2014 Apr 20;32(12):1180-2. doi: 10.1200/JCO.2013.54.6259.
    note
    Source null
    related pmid
    24638010
    relationship
    Comment in
outcomes validated
false
pmid
24637998
provenance
batch id
063b6c38419f18d4021f
provider
NCBI PubMed ESummary
record sha256
17a7cbde87b6d6f10e46ff430d053795325b7595a5a27906154bd1c9b398712d
response sha256
5abcae41e9384a85f92695ef76b244ffd933f07a58a51082c160af8743d196ad
retrieved at
2026-09-09T23:47:02.607425+00:00
publication date
display
2014 Apr 20
precision
day
year
2014
publication types
  1. Journal Article
  2. Multicenter Study
  3. Randomized Controlled Trial
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/24637998/
title
Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: Clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 trial.

Preserved source evidence · Not medical advice